Help appealing denials for this first RNA-targeted prophylaxis for HAE attacks.

Appeal Your Dawnzera Denial

Get access to this breakthrough RNA therapy for preventing hereditary angioedema attacks.

Understanding Your Dawnzera (donidalorsen) Denial

Dawnzera (donidalorsen) is the first RNA-targeted therapy approved for preventing hereditary angioedema (HAE) attacks in adults and adolescents 12 years and older. HAE causes unpredictable, potentially life-threatening swelling episodes. Insurance often requires step therapy through older prophylactic treatments first.

Common Reasons for Denial

! Prior authorization required
! Must try C1-inhibitor products first
! Must try lanadelumab first
! Step therapy requirement not met
! HAE diagnosis not adequately documented
! Ultra-high cost orphan drug concerns

How We Help

We help you document your HAE diagnosis, attack frequency and severity, prior prophylactic treatments, and why Dawnzera is the best option for preventing your attacks.

Start your Dawnzera appeal — it takes about 3 minutes.

Some Types of Evidence We Can Use For Supporting Your Appeal

✓ Donidalorsen is an antisense oligonucleotide that reduces prekallikrein synthesis, preventing the kallikrein-kinin cascade that causes HAE attacks.

✓ Clinical trials demonstrated an 81% reduction in HAE attack rate compared to placebo.

✓ HAE attacks can be life-threatening when affecting the airway and severely impact quality of life.

✓ Monthly dosing with donidalorsen offers convenience compared to more frequent injection schedules.

Patient Assistance & Copay Programs

These programs may help reduce your costs while you appeal:

Ionis Every Step (Dawnzera)

Comprehensive support including insurance navigation, financial assistance, and injection training. Free trial program available for all patients including Medicare/Medicaid. Call 1-844-444-4305.

Eligibility requirements and program terms may change. Please verify current details directly with each organization.

Patient Advocacy & Support Organizations

These organizations provide education, support, and advocacy for patients:

US Hereditary Angioedema Association

Nonprofit advocacy organization for people with HAE and their caregivers.

HAE International

Global network of HAE organizations dedicated to improving lives of people with HAE.

Frequently Asked Questions

Include your HAE diagnosis confirmation (C4, C1-inhibitor levels, genetic testing), attack diary showing frequency and severity, prior prophylactic treatments tried, and documentation of breakthrough attacks on current therapy.

Document why you need to switch, including breakthrough attacks despite current therapy, injection site reactions, or other tolerability issues with your current treatment.

Ready to Fight Your Dawnzera (donidalorsen) Denial?

Our free AI-powered tool will help you generate a compelling appeal letter in minutes.

Start Your Appeal Chat with AI Assistant

Disclaimer: Fight Health Insurance is not affiliated with, endorsed by, or partnered with any pharmaceutical manufacturer, healthcare provider, medical device company, or patient assistance program, including Ionis Pharmaceuticals. All information provided is for educational and informational purposes only and does not constitute medical or legal advice. Please consult with your healthcare provider regarding treatment options and with your insurance company regarding coverage decisions.